Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.


Autoria(s): Voutsadakis I.A.; Patrikidou A.; Tsapakidis K.; Karagiannaki A.; Hatzidaki E.; Stathakis N.E.; Papandreou C.N.
Data(s)

2010

Identificador

https://serval.unil.ch/?id=serval:BIB_05A38F987653

isbn:1432-1262[electronic], 0179-1958[linking]

pmid:20397022

doi:10.1007/s00384-010-0939-0

isiid:000278290600001

Idioma(s)

en

Fonte

International Journal of Colorectal Disease, vol. 25, no. 7, pp. 795-804

Palavras-Chave #Apoptosis/drug effects; Aspirin/pharmacology; Blotting, Western; Boronic Acids/pharmacology; Cell Line, Tumor; Cell Proliferation/drug effects; Cell Survival/drug effects; Colorectal Neoplasms/enzymology; Colorectal Neoplasms/pathology; Cyclin-Dependent Kinase Inhibitor p21/metabolism; Cyclin-Dependent Kinase Inhibitor p27/metabolism; Cyclooxygenase 2/metabolism; Down-Regulation/drug effects; Drug Synergism; Humans; NF-kappa B/metabolism; Proto-Oncogene Proteins c-akt/metabolism; Pyrazines/pharmacology; bcl-Associated Death Protein/metabolism
Tipo

info:eu-repo/semantics/article

article